AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

🇪🇬

EZETIMIBE 10.000 Mg ; SIMVASTATIN 40.000 Mg ; in Egypt

15 products registered with EDA 15 active

Brand / ProductReg. No.HolderStatusExpires
JESTAMIVAM 10/40 mg
Tablets
UNKNOWN-e8c3469aEgyptian Group for Pharmaceutical Industries - EGPIactive
VETOSIMVAMEB 10/40 mg
Tablets
UNKNOWN-5376c919vetopharm nerhado international for pharmaceuticals and chemicalsactive
SIMEZET
Film Coated Tablets
UNKNOWN-a63524d1organo for pharmaceutical and chemical industries (organo pharma)active
Vastatinal 40/10 mg
Tablets
UNKNOWN-1d90a3ebuniversal pharmaceutical industries (unipharma)active
VETOSIMVAMEB 10/40 mg
Tablets
UNKNOWN-dc809bedvetopharm nerhado international for pharmaceuticals and chemicalsactive
JESTAMIVAM 10/40 mg
Tablets
UNKNOWN-538285eeEgyptian Group for Pharmaceutical Industries - EGPIactive
SIMEZET
Film Coated Tablets
UNKNOWN-8635d1a1organo for pharmaceutical and chemical industries (organo pharma)active
Givarorock 10/40 mg
Tablets
UNKNOWN-6e8238dfChemedicaactive
SIMVASTIMIBE 10/40mg
Tablets
UNKNOWN-346c550cEva pharma for Pharmaceuticals and Medical Appliances - Eva Pharmaactive
Simvastacare 10/40 mg
Tablets
UNKNOWN-a5fb7761PHARMACARE EGYPT FOR TRADING AGENCYactive
Vastatinal 40/10 mg
Tablets
UNKNOWN-5ee73781universal pharmaceutical industries (unipharma)active
SIMVASTIMIBE 10/40mg
Tablets
UNKNOWN-24eb2dc0Eva pharma for Pharmaceuticals and Medical Appliances - Eva Pharmaactive
Simvastacare 10/40 mg
Tablets
UNKNOWN-5066b66dPHARMACARE EGYPT FOR TRADING AGENCYactive
Givarorock 10/40 mg
Tablets
UNKNOWN-a891c3c3Chemedicaactive
ALTOMANIRA
Tablets
UNKNOWN-e1814803Bio Med For Pharmaceutical Industries (BIOMED)active

EZETIMIBE 10.000 Mg ; SIMVASTATIN 40.000 Mg ;EDA Registration Details

EDA (Egypt) has 15 registered products containing EZETIMIBE 10.000 Mg ; SIMVASTATIN 40.000 Mg ;, of which 15 are currently active. Data is sourced directly from the official EDA drug register and refreshed daily.

Track EZETIMIBE 10.000 Mg ; SIMVASTATIN 40.000 Mg ; registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.